Trial Profile
Phase II trial of Very Small Embryonic-Like Stem Cells (VSEL) in patients with periodontitis
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 27 Dec 2022
Price :
$35
*
At a glance
- Drugs Autologous stem cell therapy (Primary)
- Indications Bone resorption; Periodontitis
- Focus Adverse reactions; First in man; Therapeutic Use
- Sponsors Caladrius Biosciences; Lisata Therapeutics
- 14 Apr 2015 New trial record